Health Minister Nadda Calls for Transparency in Drug Regulations to Achieve Global Standards July 18, 2024 Nadda urged CDSCO to develop a roadmap with timelines to achieve global standards in its mandated activities.
Mankind Pharma & EQT-ADIA in INR 14,000 Cr Race for BSV Group July 18, 2024 If finalized, this will be one of the largest buyouts of a domestic pharmaceutical company in India and potentially one of the most lucrative exits for a buyout fund in the sector.
Union Health Ministry to Amend Drugs Rules for Inclusion of Excipients in QR Codes July 16, 2024 The proposal to include excipient details on drug labels arose from grievances that parabens, used as preservatives in pharmaceuticals, cause allergies in many individuals.
Glenmark Pharma to Divest 7.84% Stake in Subsidiary Glenmark Life Sciences July 11, 2024 The divestment will involve 9,609,571 equity shares, to be executed through an offer for sale (OFS) on the stock exchange.
Pulsus Group to Establish AI-based Pharma Healthcare IT Hub in Telangana July 8, 2024 The new hub will leverage advanced AI technologies to optimize various aspects of the pharmaceutical industry, from research and development to healthcare delivery.
Navin Molecular to Invest $35 Mn to Expand GMP Manufacturing Plant July 5, 2024 Navin Molecular, a contract development and manufacturing organization (CDMO) based in Madhya Pradesh, has announced an investment of INR 288 Cr (approximately US$35 million) to expand its GMP manufacturing capabilities.
KPRDO Urges CDSCO to Include Pharmacy Associations' Insights in DCC Discussions July 5, 2024 The Karnataka Pharma Retailers & Distributors Organisation (KPRDO) has called on the Central Drugs Standard Control Organization (CDSCO) to include pharmacy associations' insights during the Drug Consultative Committee (DCC) Subcommittee's discussions on Rule 64 Part VI of the Drugs and Cosmetics (D&C) Act.
AstraZeneca India to Invest INR 250 Cr for Global Innovation & Tech Center in Tamil Nadu July 5, 2024 This initiative aims to enhance capabilities in enterprise platforms, artificial intelligence, machine learning, data science, and supply chain analytics for healthcare.
Emcure Pharma Raised INR 583 Cr Ahead of its on IPO on 3rd July July 4, 2024 Bain Capital-backed Emcure Pharmaceuticals raised INR 583 Cr from anchor investors, one day before its initial public offering (IPO) opened for public subscription on 3rd July.
Thyrocare Acquires Polo Labs' Diagnostic & Pathology Biz for INR 4.26 Cr July 4, 2024 Mumbai-based Thyrocare Technologies has acquired Polo Labs' diagnostic and pathology business for a cash consideration of INR 4.26 Cr.
DoP Allocates INR 243 Cr for Establishing Centers of Excellence in NIPERs July 3, 2024 The steering committee approved CoE proposals from all National Institute of Pharmaceutical Education and Research (NIPERs) and sanctioned a budget of INR 700 Cr for the next five years.
60 Small Drug Makers Join Pharma Tech Upgrade Scheme Facing Quality Concerns July 3, 2024 This move aims to enhance drug production standards and restore confidence in Indian pharmaceutical products globally.